Genistein: The potential for efficacy in rheumatoid arthritis

Clinical Rheumatology

Volumn 32, Issue 5, 2013, Pages 535-540

  Li, Jinchao ^a   Gang, Dong ^b   Yu, Xiaowei ^c   Hu, Yiping ^a   Yue, Ye ^a   Cheng, Wenxiang ^a   Pan, Xiaohua ^d   Zhang, Peng ^a  

^a Shenzhen University Town   (China)

^b Hangzhou Hospital of Traditional Chinese Medicine   (China)

^c THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^d JINAN UNIVERSITY   (China)

Author keywords

Genistein; Phytoestrogen; Rheumatoid arthritis; Therapy

Indexed keywords

ANALGESIC AGENT; ANGIOGENESIS INHIBITOR; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; GENISTEIN; GLYCOSIDE; IMMUNOMODULATING AGENT; PROTECTIVE AGENT;

ANALGESIC ACTIVITY; ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG METABOLISM; DRUG STRUCTURE; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTECTION; REVIEW; RHEUMATOID ARTHRITIS;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIOXIDANTS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CLINICAL TRIALS AS TOPIC; GENISTEIN; HUMANS; MICE; MOLECULAR STRUCTURE;

EID: 84878703304     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-012-2148-4     Document Type: Review

References (50)

1. MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, Aho K et al (2000) Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 43(1):30-37
2. Smolen JS, Kalden JR, Scott DL, Rozman B, Kvien TK, Larsen A et al (1999) Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group. Lancet 353(9149):259-266
3. McClain RM, Wolz E, Davidovich A, Edwards J, Bausch J (2007) Reproductive safety studies with genistein in rats. Food Chem Toxicol 45(8):1319-1332
4. An J, Tzagarakis-Foster C, Scharschmidt TC, Lomri N, Leitman DC (2001) Estrogen receptor beta-selective transcriptional activity and recruitment of coregulators by phytoestrogens. J Biol Chem 276(21):17808-17814
5. Dharmappa KK, Mohamed R, Shivaprasad HV, Vishwanath BS (2010) Genistein, a potent inhibitor of secretory phospholipase A2: a new insight in down regulation of inflammation. Inflammopharmacology 18(1):25-31
6. Luo LJ, Liu F, Lin ZK, Xie YF, Xu JL, Tong QC et al (2012) Genistein regulates the IL-1 beta induced activation of MAPKs in human periodontal ligament cells through G protein-coupled receptor 30. Arch Biochem Biophys 522(1):9-16
7. Kim JM, Uehara Y, Choi YJ, Ha YM, Ye BH, Yu BP et al (2011) Mechanism of attenuation of pro-inflammatory Ang II-induced NF-kappaB activation by genistein in the kidneys of male rats during aging. Biogerontology 12(6):537-550
8. Palanisamy N, Kannappan S, Anuradha CV (2011) Genistein modulates NF-kappaB-associated renal inflammation, fibrosis and podocyte abnormalities in fructose-fed rats. Eur J Pharmacol 667(1-3):355-364
9. Pettit AR, Walsh NC, Manning C, Goldring SR, Gravallese EM (2006) RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis. Rheumatology 45(9):1068-1076
10. McInnes IB, O'Dell JR (2010) State-of-the-art: rheumatoid arthritis. Ann Rheum Dis 69(11):1898-1906
11. Ullmann U, Metzner J, Frank T, Cohn W, Riegger C (2005) Safety, tolerability, and pharmacokinetics of single ascending doses of synthetic genistein (Bonistein) in healthy volunteers. Adv Ther 22(1):65-78
12. Adlercreutz H, Markkanen H, Watanabe S (1993) Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 342(8881):1209-1210
13. Birnbaum H, Shi L, Pike C, Kaufman R, Sun P, Cifaldi M (2009) Workplace impacts of anti-TNF therapies in rheumatoid arthritis: review of the literature. Expert Opin Pharmacother 10(2):255-269
14. Zintzaras E, Dahabreh IJ, Giannouli S, Voulgarelis M, Moutsopoulos HM (2008) Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens. Clin Ther 30(11):1939-1955
15. Verdrengh M, Jonsson IM, Holmdahl R, Tarkowski A (2003) Genistein as an anti-inflammatory agent. Inflamm Res 52(8):341-346
16. Sheikh A, Naqvi SH, Sheikh K (2012) Itraconazole: its possible role in inhibiting angiogenesis in Rheumatoid Arthritis. Med Hypotheses 79(3):313-314
17. Harada M, Mitsuyama K, Yoshida H, Sakisaka S, Taniguchi E, Kawaguchi T et al (1998) Vascular endothelial growth factor in patients with rheumatoid arthritis. Scand J Rheumatol 27(5):377-380
18. Levy NS, Chung S, Furneaux H, Levy AP (1998) Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J Biol Chem 273(11):6417-6423
19. Lu J, Kasama T, Kobayashi K, Yoda Y, Shiozawa F, Hanyuda M et al (2000) Vascular endothelial growth factor expression and regulation of murine collagen-induced arthritis. J Immunol 164(11):5922-5927
20. Sone H, Kawakami Y, Sakauchi M, Nakamura Y, Takahashi A, Shimano H et al (2001) Neutralization of vascular endothelial growth factor prevents collagen-induced arthritis and ameliorates established disease in mice. Biochem Bioph Res Co 281(2):562-568
21. Fotsis T, Pepper M, Adlercreutz H, Fleischmann G, Hase T, Montesano R et al (1993) Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci U S A 90(7):2690-2694
22. Buchler P, Reber HA, Buchler MW, Friess H, Lavey RS, Hines OJ (2004) Antiangiogenic activity of genistein in pancreatic carcinoma cells is mediated by the inhibition of hypoxia-inducible factor-1 and the down-regulation of VEGF gene expression. Cancer 100(1):201-210
23. Yu X, Zhu J, Mi M, Chen W, Pan Q, Wei M (2012) Anti-angiogenic genistein inhibits VEGF-induced endothelial cell activation by decreasing PTK activity and MAPK activation. Med Oncol 29(1):349-357
24. Xu JX, Zhang Y, Zhang XZ, Ma YY (2011) [Anti-angiogenic effects of genistein on synovium in a rat model of type II collagen-induced arthritis]. Zhong Xi Yi Jie He Xue Bao 9(2):186-193
25. Karouzakis E, Neidhart M, Gay RE, Gay S (2006) Molecular and cellular basis of rheumatoid joint destruction. Immunol Lett 106(1):8-13
26. Magee PJ, Rowland IR (2004) Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. Br J Nutr 91(4):513-531
27. Zhang Y, Dong J, He P, Li W, Zhang Q, Li N et al (2012) Genistein inhibit cytokines or growth factor-induced proliferation and transformation phenotype in fibroblast-like synoviocytes of rheumatoid arthritis. Inflammation 35(1):377-387
28. Li YW, Sarkar FH (2002) Inhibition of nuclear factor kappa B activation in PC3 cells by genistein is mediated via Akt signaling pathway. Clin Cancer Res 8(7):2369-2377
29. Shah D, Wanchu A, Bhatnagar A (2011) Interaction between oxidative stress and chemokines: possible pathogenic role in systemic lupus erythematosus and rheumatoid arthritis. Immunobiology 216(9):1010-1017
30. Cerhan JR, Saag KG, Merlino LA, Mikuls TR, Criswell LA (2003) Antioxidant micronutrients and risk of rheumatoid arthritis in a cohort of older women. Am J Epidemiol 157(4):345-354
31. Ruiz-Larrea MB, Mohan AR, Paganga G, Miller NJ, Bolwell GP, Rice-Evans CA (1997) Antioxidant activity of phytoestrogenic isoflavones. Free Radic Res 26(1):63-70
32. Zhang T, Wang F, Xu HX, Yi L, Qin Y, Chang H et al (2012) Activation of nuclear factor erythroid 2-related factor 2 and PPARgamma plays a role in the genistein-mediated attenuation of oxidative stress-induced endothelial cell injury. Br J Nutr 3:1-13
33. Park CE, Yun H, Lee EB, Min BI, Bae H, Choe W et al (2010) The antioxidant effects of genistein are associated with AMP-activated protein kinase activation and PTEN induction in prostate cancer cells. J Med Food 13(4):815-820
34. Permin H, Skov PS, Norn S, Juhl F (1977) Autoimmune allergic type-I reaction in pathogenesis of rheumatoid arthritis. Lancet 2(8030):200-201
35. Moots RJ (1998) A fistful of T cells. Br J Rheumatol 37(6):602-611
36. Korganow AS, Ji H, Mangialaio S, Duchatelle V, Pelanda R, Martin T et al (1999) From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 10(4):451-461
37. Kremer JM, Genant HK, Moreland LW, Russell AS, Emery P, Abud-Mendoza C et al (2006) Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial. Ann Intern Med 144(12):865-876
38. Guo TL, McCay JA, Zhang LX, Brown RD, You L, Karrow NA et al (2001) Genistein modulates immune responses and increases host resistance to B16F10 tumor in adult female B6C3F1 mice. J Nutr 131(12):3251-3258
39. Kogiso M, Sakai T, Mitsuya K, Komatsu T, Yamamoto S (2006) Genistein suppresses antigen-specific immune responses through competition with 17 beta-estradiol for estrogen receptors in ovalbumin-immunized BALB/c mice. Nutrition 22(7-8):802-809
40. Rao P, Knaus EE (2008) Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. J Pharm Pharm Sci 11(2):81s-110s
41. Liu L, Yang T, Simon SA (2004) The protein tyrosine kinase inhibitor, genistein, decreases excitability of nociceptive neurons. Pain 112(1-2):131-141
42. Valsecchi AE, Franchi S, Panerai AE, Sacerdote P, Trovato AE, Colleoni M (2008) Genistein, a natural phytoestrogen from soy, relieves neuropathic pain following chronic constriction sciatic nerve injury in mice: anti-inflammatory and antioxidant activity. J Neurochem 107(1):230-240
43. Valsecchi AE, Franchi S, Panerai AE, Rossi A, Sacerdote P, Colleoni M (2011) The soy isoflavone genistein reverses oxidative and inflammatory state, neuropathic pain, neurotrophic and vasculature deficits in diabetes mouse model. Eur J Pharmacol 650(2-3):694-702
44. Wang JG, Ruan J, Li CY, Wang JM, Li Y, Zhai WT et al (2011) Connective tissue growth factor, a regulator related with 10-hydroxy-2-decenoic acid down-regulate MMPs in rheumatoid arthritis. Rheumatol Int 32(9):2791-2799
45. Kousidou OC, Mitropoulou TN, Roussidis AE, Kletsas D, Theocharis AD, Karamanos NK (2005) Genistein suppresses the invasive potential of human breast cancer cells through transcriptional regulation of metalloproteinases and their tissue inhibitors. Int J Oncol 26(4):1101-1109
46. Li Y, Che M, Bhagat S, Ellis KL, Kucuk O, Doerge DR et al (2004) Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein. Neoplasia 6(4):354-363
47. Gao YH, Yamaguchi M (1999) Inhibitory effect of genistein on osteoclast-like cell formation in mouse marrow cultures. Biochem Pharmacol 58(5):767-772
48. Sugimoto E, Yamaguchi M (2000) Anabolic effect of genistein in osteoblastic MC3T3-E1 cells. Int J Mol Med 5(5):515-520
49. Polkowski K, Mazurek AP (2000) Biological properties of genistein. A review of in vitro and in vivo data. Acta Pol Pharm 57(2):135-155
50. Messing E, Gee JR, Saltzstein DR, Kim K, diSant'Agnese A, Kolesar J et al (2012) A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients. Cancer Prev Res (Phila) 5(4):621-630